Diversified Healthcare Trust – (NASDAQ:DHCNI) Sees Significant Growth in Short Interest

Diversified Healthcare Trust – (NASDAQ:DHCNI) saw a significant growth in short interest during the month of June. As of June 30th, there was short interest totaling 54,805 shares, a growth of 190.2% from the June 15th total of 18,882 shares. Based on an average daily trading volume, of 39,049 shares, the short-interest ratio is presently 1.4 days.

Diversified Healthcare Trust Stock Performance

Shares of NASDAQ DHCNI traded up $0.14 during mid-day trading on Monday, reaching $18.06. 7,889 shares of the company traded hands, compared to its average volume of 66,743. The company’s fifty day moving average is $18.29 and its two-hundred day moving average is $17.62. Diversified Healthcare Trust has a fifty-two week low of $15.61 and a fifty-two week high of $19.09.

Diversified Healthcare Trust Dividend Announcement

The business also recently announced a quarterly dividend, which will be paid on Saturday, August 1st. Shareholders of record on Wednesday, July 15th will be given a dividend of $0.3516 per share. The ex-dividend date of this dividend is Wednesday, July 15th. This represents a $1.41 dividend on an annualized basis and a yield of 7.8%.

Diversified Healthcare Trust (NASDAQ: DHCNI) is a publicly traded real estate investment trust (REIT) specializing in healthcare and life science properties. The company’s primary business activities include the acquisition, development, ownership and management of net?leased medical office buildings, senior housing facilities and life science research and development assets. In addition to property investments, Diversified Healthcare Trust holds mortgage loans and preferred equity interests in the healthcare sector, offering diversified exposure to both real estate and structured financing arrangements.

The company’s portfolio spans a broad range of healthcare asset types, including medical office buildings leased to health systems and physician groups, senior living communities operated by leading care providers, and life science campuses serving biotechnology and pharmaceutical companies.